
Search
Filter Results
Displaying 61–70 of 662 for “retinitis clinical trial”
-
-
Jun 27, 2022
Kiora to Launch Clinical Trial in Australia for Vision-Restoring Small Molecule for RP Patients
The approach bestows light sensitivity to retinal ganglion cells for people who have lost their photoreceptors
-
Jul 19, 2021
Nanoscope Therapeutics Launches Phase 2b Clinical Trial for Optogenetic Therapy
While the trial is for people with RP, the company hopes it will also benefit people with other retinal degenerative diseases
-
Oct 20, 2020
RP Treatment Derived from Induced Pluripotent Stem Cells Advances into Clinical Trial
The stem cells were derived from mature blood cells and coaxed to become photoreceptors
-
Mar 15, 2022
Aldeyra Launches Phase 2 Clinical Trial of Methotrexate Intravitreal Injections for RP
Lab studies showed the drug can effectively address the misfolded rhodopsin protein
-
Dec 21, 2017
jCyte Reports Results for Phase 1/2a Clinical Trial for Retinal-Cell Treatment
Some participants reported increased light sensitivity, improved color vision, better mobility, and improved reading ability.
-
Oct 30, 2024
BlueRock’s Photoreceptor Cell Therapy to Move into Clinical Trial
The Foundation funded Dr. David Gamm for development of the induced pluripotent stem cell approach to be used in the trial.
-
Sep 24, 2021
MeiraGTx and Janssen Recruiting for Phase 3 XLRP Gene Therapy Clinical Trial
Visit www.LUMEOSstudy.com for more information about trial
-
May 16, 2024
No serious adverse events were reported. One patient had encouraging improvement in retinal sensitivity.
-
Aug 4, 2020
4D Molecular Therapeutics Launches Phase 1 Clinical Trial for Choroideremia Gene Therapy
Gene therapy delivered by intravitreal injection